<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03076515</url>
  </required_header>
  <id_info>
    <org_study_id>TCH_002</org_study_id>
    <nct_id>NCT03076515</nct_id>
  </id_info>
  <brief_title>Migraine Treatment With Nerivio Migra Neurostimulation Device</brief_title>
  <official_title>A Prospective, Randomized, Double-blind, Sham Controlled Multi-center Clinical Trial, Migraine Headache Treatment With Nerivio Migra Neurostimulation Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Theranica</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Theranica</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, randomized, double-blind, sham controlled multi-center trial. Ratio
      between treatment and control groups will be 1:1, stratified by center and use of preventive
      medications.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study was prematurely stop based on DMC recommendation
  </why_stopped>
  <start_date type="Actual">April 2, 2017</start_date>
  <completion_date type="Actual">April 1, 2018</completion_date>
  <primary_completion_date type="Actual">January 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain relief</measure>
    <time_frame>2 hours post treatment</time_frame>
    <description>Percentage of patients reporting freedom from pain (pain grade 0) 2 hours post treatment without rescue medications in at least 50% of treated attacks</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Acute Migraine</condition>
  <arm_group>
    <arm_group_label>Nerivio Migra active</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Nerivio Migra placebo</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nerivio Migra neurostimulation</intervention_name>
    <description>transcutaneous electrical stimulation</description>
    <arm_group_label>Nerivio Migra active</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham Nerivio Migra</intervention_name>
    <description>electrical stimulation- shame mode</description>
    <arm_group_label>Nerivio Migra placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient is 18-75 years old.

          2. Patient meeting the ICHD-3 diagnostic criteria for migraine with and without aura.

          3. Patients reporting 2-8 migraine attacks per month.

          4. Patient must be able and willing to comply with the protocol.

          5. Patient must be able and willing to provide written informed consent.

          6. Male or non-pregnant / non-lactating female (NOTE: Females of child bearing potential
             must have a negative pregnancy test) and must be willing to use adequate contraceptive
             means during the study

        Exclusion Criteria:

          1. Has other significant pain problem that in the opinion of the investigator may
             confound the study assessments

          2. Is currently implanted with an electrical and/or neurostimulator device (e.g. cardiac
             pacemaker or defibrillator, vagus nerve neurostimulator, deep brain stimulator, spinal
             stimulator, bone growth stimulator cochlear implant, Sphenopalatine ganglion
             stimulator or Occipital nerve stimulator).

          3. Known uncontrolled epilepsy.

          4. Use of Cannabis including medical use.

          5. Has chronic migraine (more than 15 headache days per month).

          6. Changed usage or dosage of migraine preventive medications in the last two months

          7. Has undergone nerve block (occipital or other) in the head or neck within the last 2
             weeks.

          8. Is participating in any other clinical study. -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian M Grosberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hartford Healthcare Headache Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>MedStar - Georgetown University Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albany Medical College</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hartford Healthcare Headache Center</name>
      <address>
        <city>Hartford</city>
        <state>New York</state>
        <zip>06103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwell Health, Inc</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>11042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hillel Yaffe Medical Center</name>
      <address>
        <city>Hadera</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herzeliya medical Center</name>
      <address>
        <city>Herzliya</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maccabi Healthcare neurology clinics</name>
      <address>
        <city>Kefar Saba</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Western Galilee Medical Center</name>
      <address>
        <city>Nahariya</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2017</study_first_submitted>
  <study_first_submitted_qc>March 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2017</study_first_posted>
  <last_update_submitted>May 3, 2018</last_update_submitted>
  <last_update_submitted_qc>May 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

